• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Boehringer Ingelheim to sell veterinary vaccine portfolio to Elanco

October 12, 2016

Pending FTC approval of Merial acquisition, BI will sell Duramune, ULTRA, Fel-O-Vax and other lines.

Boehringer Ingelheim Vetmedica has agreed to sell its portfolio of U.S. canine, feline and rabies vaccines, as well as the manufacturing and R&D site, to Elanco Animal Health for a price of $885 million, according to a company release. This price includes the estimated cost of acquired inventory. The sale is conditioned on antitrust approval and the Boehringer Ingelheim/Sanofi asset swap that was signed in June 2016.

“This agreement is an important step toward a successful acquisition of Merial,” says Dr. Albrecht Kissel, president and CEO of Boehringer Ingelheim Vetmedica, in the release. “This was a highly complex decision from a business and from an emotional perspective. It was certainly not taken lightly particularly in view of the history and significant positive developments of this business over the past years.

“We are confident that, under Elanco's leadership, customers will continue to have access to these innovative vaccines and the portfolio will have strong support,” Kissel says.

The sale to Elanco is anticipated to close in early 2017 subject to approval from the Federal Trade Commission and other contingencies, the release states.  

Vaccines included in the proposed sale:

Canine:

> Duramune

> Duramune Max 5/4L

> Duramune Max 5

> Duramune Max 5-Cvk/4L

> Duramune Max 5-Cvk

> Duramune Max Pv   

> Duramune CV-K

> Duramune Max PC

> Duramune Adult 3

> LeptoVax 4

> LeptoVax 4/C

> Bronchi-Shield

Advertisement

> Bronchi-Shield ORAL

> Bronchi-Shield III

> Duramune Lyme

> Duramune Lyme

> Duramune Lyme +LeptoVax 4

> Duramune Lyme +Leptovax 4/C

> Duramune Lyme +Max 5/4L

> Duramune Lyme +Max5-CvK/4L

> Duramune Lyme +Max5-CvK

> ULTRA Duramune

> ULTRA Duramune DAP+4L

> ULTRA Duramune DAP

> ULTRA Duramune 4L

> ULTRA Duramune DAP+C4L

> ULTRA Duramune DAP+C

> ULTRA Duramune Lyme

Feline:

> Fel-O-Vax

> Fel-O-Vax Lv-K III + CaliciVax

> Fel-O-Vax Lv-K

> Fel-O-Vax Lv-K/FIV

> Fel-O-Vax IV+CaliciVax

> Fel-O-Vax PCT+CaliciVax

> Fel-O-Vax Lv-K IV+CaliciVax

> Fel-O-Vax FIV

> CaliciVax

> ULTRA Fel-O-Vax

> ULTRA Fel-O-Vax FVRCP+FeLV

> ULTRA Fel-O-Vax FVRCP

> ULTRA Fel-O-Vax FeLV

> ULTRA Fel-O-Vax Dual FCV

> ULTRA Hybrid FVRCP

> Fel-O-Guard

> Fel-O-Guard Plus 3

> Fel-O-Guard Plus 3+Lv-K

> Fel-O-Guard Plus 4

> Fel-O-Guard Plus 4 +Lv-K

Rabies:

> Rabvac

> Rabvac 3

> Rabvac 1

Related Content:

Market TrendsRegulatoryBreaking News
Market research: How to find your edge
Market research: How to find your edge
USDA aims to strengthen handling regulations for exotic animals in exhibition
USDA aims to strengthen handling regulations for exotic animals in exhibition
Embrace Pet Insurance joins acclaimed pet insurance marketplace
Embrace Pet Insurance joins acclaimed pet insurance marketplace

Advertisement

Latest News

San Francisco SPCA bestows $100k grant from San Francisco Foundation

Merck Animal Hospital renews scholarship with The Foundation for the Horse

3 Must-reads from Fetch Charlotte 2023

A practical approach to a fever of unknown origin

View More Latest News
Advertisement